Revelation Biosciences Inc expected to post a loss of 33 cents a share - Earnings Preview

Revelation Biosciences

12/08/2023 03:08

* Revelation Biosciences Inc  REVB.OQ   REVB.O  is expected
to show no change in quarterly revenue when it reports 
results on November 8 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Revelation
Biosciences
Inc is for a loss of 33 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts had risen by
about 16.7%
in the last three months. ​
    * Wall Street's median 12-month price target for Revelation
Biosciences Inc is $11.45​, above​ its last closing price
of $0.75. ​​​

This summary was machine generated August 12 at 02:08 GMT.  All
figures in US dollars  unless otherwise stated